Viewing Study NCT00116051



Ignite Creation Date: 2024-05-05 @ 11:43 AM
Last Modification Date: 2024-10-26 @ 9:12 AM
Study NCT ID: NCT00116051
Status: COMPLETED
Last Update Posted: 2009-07-07
First Post: 2005-06-26

Brief Title: A Comparison of Two Surface Materials Tantalum Versus Titanium Fiber Mesh of Acetabular Components in Hip Arthroplasty
Sponsor: University of Aarhus
Organization: University of Aarhus

Study Overview

Official Title: A Comparison of Two Surface Materials Tantalum Versus Titanium Fiber Mesh of Acetabular Components in Hip Arthroplasty
Status: COMPLETED
Status Verified Date: 2009-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to compare two surface materials tantalum versus titanium fiber mesh of acetabular components in hip arthroplasty
Detailed Description: In younger patients acetabulum components are most often implanted without the use of cement A direct ingrowth of bone to the implant is crucial to the attainment of good results in those cases where cement is not employed A new implant material tantalum has shown better properties than the implant material which is in use today titanium The advantages of tantalum implants are greater porosity reduced stiffness and a higher friction coefficient than with titanium implants

Hypothetically the higher porosity of tantalum should enhance bone ingrowth due to better osteoconductivity in terms of

1 less migration of the acetabulum component as evaluated by RSA
2 increased BMD in the bone surrounding acetabulum components
3 fewer postoperative complaints on the Harris Hip Score and visual analog scale scores

The migration of acetabulum components will be evaluated by RSA The follow-up RSA will be scheduled for week 1 as well as 3 months 12 months and 2 years after surgery Bone mineral density around the implanted femoral component will be examined by DEXA scan at week 1 as well as 1 year and 2 years after surgery

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None